Bağışıklığı Baskılanmış Bireylerde Tüberküloz
References
World Health Organization. Global Tuberculosis Report 2025. (16/04/2026 tarihinde https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025 adresinden ulaşılmıştır).
Santín Cerezales M, Navas Elorza E. Tuberculosis in special populations. Enfermedades infecciosas y microbiologia clinica. 2011;29 Suppl 1: 20-5. doi:10.1016/s0213-005x(11)70014-3
Flynn JL, Chan J. Immunology of tuberculosis. Annual review of immunology. 2001;19: 93-129. doi:10.1146/annurev.immunol.19.1.93
O'Garra A, Redford PS, McNab FW, et al. The immune response in tuberculosis. Annual review of immunology. 2013;31: 475-527. doi:10.1146/annurev-immunol-032712-095939
Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nature reviews. Microbiology. 2018;16(2): 80-90. doi:10.1038/nrmicro.2017.128
Lin PL, Plessner HL, Voitenok NN, et al. Tumor necrosis factor and tuberculosis. The journal of investigative dermatology. Symposium proceedings. 2007;12(1): 22-5. doi:10.1038/sj.jidsymp.5650027
T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Tüberküloz Tanı ve Tedavi Rehberi, 3. Baskı, Sağlık Bakanlığı Yayın No: 1387, Ankara, Nisan 2026. ISBN: 978-625-93191-3-1.
Sharma SK, Mohan A, Tamilarasu K. HIV-TB co-infection: Epidemiology, diagnosis & management. The Indian journal of medical research. 2005;121(4): 550-67.
Lange B, Brehm TT, Arend SM, et al. Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study. The Journal of infection. 2026;92(1): 106668. doi:10.1016/j.jinf.2025.106668
Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. The European respiratory journal. 2012;40(4): 990-1013. doi:10.1183/09031936.00000712
Meije Y, Piersimoni C, Torre-Cisneros J, et al. Mycobacterial infections in solid organ transplant recipients. Clinical microbiology and infection. 2014;20 Suppl 7: 89-101. doi:10.1111/1469-0691.12641
Imbert de Trémiolles G, Nguyen S, Lebeaux D, et al. Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country. Bone marrow transplantation. 2026;61(4): 469-76. doi:10.1038/s41409-026-02800-9
Al-Anazi KA, Al-Jasser AM, Alsaleh K. Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation. Frontiers in oncology. 2014;4: 231. doi:10.3389/fonc.2014.00231
Bergeron A, Mikulska M, De Greef J, et al. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. The Lancet. Infectious diseases. 2022;22(12): e359-e69. doi:10.1016/s1473-3099(22)00227-4
Cantini F, Nannini C, Niccoli L, et al. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmunity reviews. 2015;14(6): 503-9. doi:10.1016/j.autrev.2015.01.011
Shofa NM, Setiyari Mudjari N, Ekawati R, et al. Adalimumab Therapy for Crohn's Disease and Axial Spondyloarthritis in Latent Tuberculosis: A bibliometric-systematic literature review. Sultan Qaboos University medical journal. 2026;26(1): 171-83. doi:10.18295/2075-0528.2971
Jha DK, Kakadiya R, Sharma A, et al. Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: A comprehensive review. Autoimmunity reviews. 2025;24(3): 103758. doi:https://doi.org/10.1016/j.autrev.2025.103758
Picchianti-Diamanti A, Aiello A, De Lorenzo C, et al. Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents. Frontiers in immunology. 2025;Volume 16 - 2025. doi:10.3389/fimmu.2025.1494283
Cheng MP, Abou Chakra CN, Yansouni CP, et al. Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis. Clinical infectious diseases. 2017;64(5): 635-44. doi:10.1093/cid/ciw838
Anibarro L, Pena A. Tuberculosis in patients with haematological malignancies. Mediterranean journal of hematology and infectious diseases. 2014;6(1): e2014026. doi:10.4084/mjhid.2014.026
Ganzel C, Silverman B, Chemtob D, et al. The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study. Leukemia & lymphoma. 2019;60(3): 720-5. doi:10.1080/10428194.2018.1499904
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. American journal of respiratory and critical care medicine. 2000;161(4 Pt 2): S221-47. doi:10.1164/ajrccm.161.supplement_3.ats600
Vozoris NT, Seemangal J, Batt J. Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients. The European respiratory journal. 2014;44(5): 1373-5. doi:10.1183/09031936.00076714
Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Human genetics. 2020;139(6-7): 993-1000. doi:10.1007/s00439-020-02120-y
Conti F, Lugo-Reyes SO, Blancas Galicia L, et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. The Journal of allergy and clinical immunology. 2016;138(1): 241-8.e3. doi:10.1016/j.jaci.2015.11.041
World Health Organization. Operational handbook on tuberculosis: module 6: tuberculosis and comorbidities, 3rd ed. (17/04/2026 tarihinde https://www.who.int/publications/i/item/9789240103276 adresinden ulaşılmıştır)
Luczynski P, Holmes T, Romanowski K, et al. Risk of Tuberculosis Disease in People With Chronic Kidney Disease Without Kidney Failure: A Systematic Review and Meta-analysis. Clinical infectious diseases. 2023;77(8): 1194-200. doi:10.1093/cid/ciad364
Centers for Disease Control and Prevention. Clinical overview of tuberculosis disease. (20/04/2026 tarihinde https://www.cdc.gov/tb/hcp/clinical-overview/tuberculosis-disease.html. adresinden ulaşılmıştır).
Centers for Disease Control and Prevention. Clinical care for people with TB and HIV. (20/04/2026 tarihinde https://www.cdc.gov/tb/hcp/clinical-care/hiv.html. adresinden ulaşılmıştır).
Developed by the National Institutes of Health, the HIV Medicine Association,
and the Infectious Diseases Society of America Panel 2024. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. (21/04/2026 tarihinde https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/mycobacterium adresinden ulaşılmıştır).
Aceves-Sánchez B, Rajme-López S, Martínez-Guerra BA, et al. Distinct Clinical Features of Extrapulmonary and Disseminated Tuberculosis in HIV- and Non-HIV-Associated Immunosuppression: A Retrospective Cohort Study. Open forum infectious diseases. 2025;12(5). doi:10.1093/ofid/ofaf239
Chiang C-Y, Chen C-H, Feng J-Y, et al. Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan. Journal of the Formosan Medical Association. 2023;122(10): 976-85. doi:https://doi.org/10.1016/j.jfma.2023.04.025
Chen C-Y, Sheng W-H, Cheng A, et al. Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies. BMC infectious diseases. 2011;11(1): 324. doi:10.1186/1471-2334-11-324
Andreu J, Cáceres J, Pallisa E, et al. Radiological manifestations of pulmonary tuberculosis. European Journal of Radiology. 2004;51(2): 139-49. doi:https://doi.org/10.1016/j.ejrad.2004.03.009
Kim JY, Jeong YJ, Kim KI, et al. Miliary tuberculosis: a comparison of CT findings in HIV-seropositive and HIV-seronegative patients. The British journal of radiology. 2010;83(987): 206-11. doi:10.1259/bjr/95169618
Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical Infectious Diseases. 2017;64(2): e1-e33. doi:10.1093/cid/ciw694
Centers for Disease Control and Prevention. Clinical and laboratory diagnosis for tuberculosis. 2025. (21/04/2026 tarihinde https://www.cdc.gov/tb/hcp/testing-diagnosis/clinical-and-laboratory-diagnosis.html adresinden ulaşılmıştır).
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis. (21/04/2026 tarihinde https://www.who.int/publications/i/item/9789240107984 adresinden ulaşılmıştır).
European Centre for Disease Prevention and Control. Handbook on tuberculosis laboratory diagnostic methods in the European Union – Updated 2026. Stockholm: ECDC; 2026. ISBN 978-92-9498-870-6.
Centers for Disease Control and Prevention. Clinical testing guidance for tuberculosis: tuberculin skin test. (22/04/2026 tarihinde https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html. adresinden ulaşılmıştır).
Fragoulis GE, Nikiphorou E, Dey M, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases. 2023;82(6): 742-53. doi:10.1136/ard-2022-223335
UpToDate. Menzies D. Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening). (03/05/2026 tarihinde https://www.uptodate.com/contents/tuberculosis-infection-latent-tuberculosis-in-adults-approach-to-diagnosis-screening? adresinden ulaşılmıştır).
Gopalaswamy R, Dusthackeer VNA, Kannayan S, et al. Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance. Journal of Respiration. 2021;1(2): 141-64.
European Centre for Disease Prevention and Control. Handbook on tuberculosis laboratory diagnostic methods in the European Union – Updated 2025. Stockholm: ECDC; 2025. ISBN 978-92-9498-853-9.
World Health Organization. WHO operational handbook on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition. (03/05/2026 tarihinde https://www.who.int/publications/i/item/9789240097773 adresinden ulaşılmıştır).
Centers for Disease Control and Prevention. Treatment for latent tuberculosis infection. (03/05/2026 tarihinde https://www.cdc.gov/tb/hcp/treatment/latent-tuberculosis-infection.html. adresinden ulaşılmıştır).
Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical infectious diseases. 2016;63(7): e147-e95. doi:10.1093/cid/ciw376
Saukkonen JJ, Duarte R, Munsiff SS, et al. Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. American journal of respiratory and critical care medicine. 2025;211(1): 15-33. doi:10.1164/rccm.202410-2096ST
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment — drug-susceptible tuberculosis treatment. (03/05/2026 tarihinde https://www.who.int/publications/i/item/9789240048126 adresinden ulaşılmıştır).
World Health Organization. WHO consolidated operational handbook on tuberculosis. Module 4: treatment and care. (04/05/2026 tarihinde https://www.who.int/publications/i/item/9789240108141 adresinden ulaşılmıştır).